Adamis Pharmaceuticals Corp (ADMP): Yes this is a long hold and Covid play

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Adamis Pharmaceuticals Corp (ADMP)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	42
Posts	14490
Boards Moderated	0
Alias Born	01/28/2016

Re: None

Monday, 08/03/2020 12:04:05 PM

Monday, August 03, 2020 12:04:05 PM

Yes this is a long hold and Covid play

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ADMP News

Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:50:07 PM
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus • GlobeNewswire Inc. • 09/07/2023 04:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:45:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:30:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 09:20:33 PM
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/21/2023 01:15:00 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:38:44 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 08/10/2023 08:03:30 PM
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering • GlobeNewswire Inc. • 08/04/2023 05:43:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:59:45 PM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/03/2023 08:55:39 PM
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering • GlobeNewswire Inc. • 08/02/2023 12:30:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/02/2023 04:15:27 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:13:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2023 09:01:12 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/28/2023 08:58:05 PM
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert • GlobeNewswire Inc. • 07/28/2023 12:30:00 PM
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/27/2023 10:08:01 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/27/2023 01:17:09 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:20:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:15:12 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/13/2023 08:37:24 PM
Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 06/26/2023 11:30:00 AM
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention • GlobeNewswire Inc. • 06/22/2023 11:30:00 AM
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals • GlobeNewswire Inc. • 05/25/2023 08:26:08 PM

More ADMP News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow